| Schedule of Disaggregation of Revenue |
The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance: | | | | | | | | | | | | | | | | | | | | | | | Year Ended June 30, | (in thousands) | 2026 | | | | | | 2025 | | 2024 | | Senior: | | | | | | | | | | | | | | | | | | | | | Medicare advantage commissions | $ | 510,810 | | | | | | | $ | 518,031 | | | $ | 569,648 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Senior commissions | 17,390 | | | | | | | 11,397 | | | 11,237 | | | Other services | 47,747 | | | | | | | 70,965 | | | 74,964 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Senior revenue | 575,947 | | | | | | | 600,393 | | | 655,849 | | | Healthcare Services: | | | | | | | | | | | Pharmacy | 830,854 | | | | | | | 728,753 | | | 464,853 | | | Other services | 14,081 | | | | | | | 13,952 | | | 13,655 | | | Total Healthcare Services revenue | 844,935 | | | | | | | 742,705 | | | 478,508 | | | Life: | | | | | | | | | | | | | | | | | | | | | Term commissions | 80,045 | | | | | | | 74,685 | | | 73,980 | | | Final expense commissions | 85,019 | | | | | | | 78,175 | | | 64,138 | | | Other services | 20,975 | | | | | | | 20,118 | | | 19,812 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Life revenue | 186,039 | | | | | | | 172,978 | | | 157,930 | | | All other: | | | | | | | | | | | Commissions | 18,540 | | | | | | | 17,308 | | | 35,244 | | | Other services | 1,687 | | | | | | | 718 | | | 984 | | Total All other revenue | 20,227 | | | | | | | 18,026 | | | 36,228 | | | Eliminations: | | | | | | | | | | | Commissions | (3,603) | | | | | | | (3,339) | | | (2,567) | | | | | | | | | | | | | Other services | (5,046) | | | | | | | (4,169) | | | (4,172) | | | Total Elimination revenue | (8,649) | | | | | | | (7,508) | | | (6,739) | | | Total Commissions and other services revenue | 787,645 | | | | | | | 797,841 | | | 856,923 | | | Total Pharmacy revenue | 830,854 | | | | | | | 728,753 | | | 464,853 | | | | | | | | | | | | | Total Revenue | $ | 1,618,499 | | | | | | | $ | 1,526,594 | | | $ | 1,321,776 | |
|
| Schedule of Activity in Commissions Receivable |
A roll forward of commissions receivable (current and long-term) is shown below for the period presented: | | | | | | | | | | | (in thousands) | | | | | Balance as of June 30, 2024 | | $ | 881,317 | | | Commission revenue from revenue recognized | | 317,787 | | | | Net commission revenue adjustment from change in estimate | | (4,468) | | | | Amounts recognized as accounts receivable, net | | (243,808) | | | Balance as of June 30, 2025 | | $ | 950,828 | | | | Commission revenue from revenue recognized | | 281,490 | | | | Net commission revenue adjustment from change in estimate | | 22,167 | | | | Amounts recognized as accounts receivable, net | | (263,082) | | | Balance as of June 30, 2026 | | $ | 991,403 | | |
|
| Schedule of Contract Liabilities |
A roll forward of contract liabilities (current) is shown below for the period presented: | | | | | | | | | | | (in thousands) | | | | | Balance as of June 30, 2024 | | $ | 8,066 | | | | Commission and other services revenue recognized | | (34,808) | | | | Amounts recognized as contract liabilities | | 27,440 | | | Balance as of June 30, 2025 | | $ | 698 | | | | Commission and other services revenue recognized | | (13,438) | | | | | | | | Amounts recognized as contract liabilities | | 13,639 | | | Balance as of June 30, 2026 | | $ | 899 | | |
|